SLNCF supply chain intelligence for Silence Therapeutics plc: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Silence Therapeutics plc (SLNCF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| AZN | AstraZeneca PLC | 72% | esources and assessing performance of the operating segments, has been identified as the Group’s Board. The Group has a single reportable segment (see note 4). F-16 SILENCE THERAPEUTICS plc NOTES TO … |
| AZN | AstraZeneca PLC | 72% | Reciprocal relationship from AZN graph: Reciprocal relationship from SLNCF graph: Reciprocal relationship from AZN graph: Reciprocal relationship from SLNCF graph: Reciprocal relationship from AZN gr… |
| SNYNF | Sanofi | 72% | on, we may have to establish alternative manufacturing sources. This would require substantial capital on our part, which we may not be able to obtain on commercially acceptable terms or at all. Addi… |
| SNYNF | Sanofi | 72% | Reciprocal relationship from SNYNF graph: Reciprocal relationship from SLNCF graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SLNCF graph: Reciprocal relationship from SN… |
| TKPHF | Takeda Pharmaceutical Company Limited | 72% | esources and assessing performance of the operating segments, has been identified as the Group’s Board. The Group has a single reportable segment (see note 4). F-16 SILENCE THERAPEUTICS plc NOTES TO … |
| TKPHF | Takeda Pharmaceutical Company Limited | 72% | Reciprocal relationship from TKPHF graph: Reciprocal relationship from SLNCF graph: Reciprocal relationship from TKPHF graph: Reciprocal relationship from SLNCF graph: esources and assessing performa… |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| AZN | AstraZeneca PLC | 100.00 | 1 | ['customer'] |
| SNYNF | Sanofi | 100.00 | 1 | ['customer'] |
| TKPHF | Takeda Pharmaceutical Company Limited | 100.00 | 1 | ['customer'] |
| CTNM | Contineum Therapeutics, Inc. | 50.00 | 2 | |
| ANRO | Alto Neuroscience, Inc. | 50.00 | 2 | |
| AXSM | Axsome Therapeutics, Inc. | 50.00 | 2 | |
| CLYM | Climb Bio, Inc. | 50.00 | 2 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 50.00 | 2 | |
| DEO | Diageo plc | 50.00 | 2 | |
| CYTOF | Altamira Therapeutics Ltd. | 50.00 | 2 | |
| CRVS | Corvus Pharmaceuticals, Inc. | 50.00 | 2 | |
| BIOA | BioAge Labs, Inc. | 50.00 | 2 | |
| CYTK | Cytokinetics, Incorporated | 50.00 | 2 | |
| CBIO | Crescent Biopharma, Inc. | 50.00 | 2 | |
| CCCC | C4 Therapeutics, Inc. | 50.00 | 2 | |
| DNTH | Dianthus Therapeutics, Inc. | 50.00 | 2 | |
| CCEP | Coca-Cola Europacific Partners PLC | 50.00 | 2 | |
| DSGN | Design Therapeutics, Inc. | 50.00 | 2 | |
| DAWN | Day One Biopharmaceuticals Inc | 50.00 | 2 | |
| ANL | Adlai Nortye Ltd. | 50.00 | 2 |